Characteristics and Outcomes of Acute Leukemias in Adolescents and Young Adults with Down Syndrome: A Single-Center Experience

<b>Background/Objectives:</b> Acute leukemias in adolescents and young adults (AYAs) with Down Syndrome (DS) are understudied. <b>Methods</b>: This was a single-center, retrospective cohort study. Medical records for pediatric DS (<i>n</i> = 41) and AYA-DS (<i>n</i> = 7) treated with a pediatric chemotherapy regimen for acute leukemia were evaluated. <b>Results</b>: Two-year event-free survival (EFS) in AYA DS acute leukemia patients was lower than that in their pediatric DS counterparts (28.6% (Confidence Interval (CI) 4.1, 61.2) vs. 84.9% (CI 69.5, 92.9); <i>p</i> = 0.002). <b>Conclusions</b>: Additional research is needed to improve outcomes in AYA DS leukemia.

Authors

Institutions

Publication Details

Journal
Hematology Reports
Published
2025-12-18
DOI
https://doi.org/10.3390/hematolrep17060070
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristics and Outcomes of Acute Leukemias in Adolescents and Young Adults with Down Syndrome: A Single-Center Experience

Jenny Chen, Marie Nour Karam, Sandeep Batra, Sandra K. Althouse et al.
Hematology Reports
Acute Lymphoblastic Leukemia research
article

Characteristics and Outcomes of Acute Leukemias in Adolescents and Young Adults with Down Syndrome: A Single-Center Experience

Jenny Chen, Marie Nour Karam, Sandeep Batra, Sandra K. Althouse, Megan E. Andrews
article en

Abstract

<b>Background/Objectives:</b> Acute leukemias in adolescents and young adults (AYAs) with Down Syndrome (DS) are understudied. <b>Methods</b>: This was a single-center, retrospective cohort study. Medical records for pediatric DS (<i>n</i> = 41) and AYA-DS (<i>n</i> = 7) treated with a pediatric chemotherapy regimen for acute leukemia were evaluated. <b>Results</b>: Two-year event-free survival (EFS) in AYA DS acute leukemia patients was lower than that in their pediatric DS counterparts (28.6% (Confidence Interval (CI) 4.1, 61.2) vs. 84.9% (CI 69.5, 92.9); <i>p</i> = 0.002). <b>Conclusions</b>: Additional research is needed to improve outcomes in AYA DS leukemia.

Hematology ReportsVol. 17(6)
Indiana University Health (US), Riley Hospital for Children (US), Center for Cancer and Blood Disorders (US), Indiana University School of Medicine, Indiana University – Purdue University Indianapolis (US)
Openalex Percentile: Top 48%
Acute Lymphoblastic Leukemia research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.